Legal Innovators Interview Series - The General Counsel At Covis Pharma Discusses The World Of Pharmaceutical Approvals Around The Globe - Corporate Counsel (Podcast)
With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
On this episode of The Legal Innovators Interview Series podcast, Edward John Allera, shareholder and co-chair of the firm's FDA group and Matthew Fedowitz, shareholder in the firm's IP section...
United StatesFood, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.
On this episode of The Legal Innovators Interview Series
podcast, Edward John Allera, shareholder and co-chair of the
firm's FDA group and Matthew Fedowitz, shareholder in the
firm's IP section who focuses on the life sciences industry,
sit down with Francesco Tallarico, General Counsel at Covis Pharma.
The group discusses the world of pharmaceutical approvals around
the globe and the legal hurdles that coincide.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.